Stanford biologists and engineers are working with gold nanoparticles to identify tumor margins practically down to the level of the individual cell.
According to an article from the school’s news office, the team has successfully tested the PET/CT technique in mice.
“In the lab we're now getting to a point where we can actually start asking these cancer cells real questions, like, for example, are you responding to the treatment we're giving you or not?” says Adam de la Zerda, PhD, whose work is inspired in part by the loss of a friend to brain cancer.
Read the piece:
Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.